Shorten G D, Bissonnette B, Hartley E, Nelson W, Carr A S
Department of Anaesthesia, Hospital for Sick Children, University of Toronto, Ontario, Canada.
Can J Anaesth. 1995 Jan;42(1):8-11. doi: 10.1007/BF03010563.
It is common practice at the Hospital for Sick Children, Toronto, to administer atropine 20 micrograms.kg-1 prior to succinylcholine in infants and children. It is unclear whether "prophylactic" administration of this dose of atropine to older children (6-16 yr) is necessary. This study was designed to compare the changes in heart rate, rhythm and mean arterial pressure after administration of either atropine 10 or 20 micrograms.kg-1 with succinylcholine or vecuronium (control group) to older children anaesthetized with thiopentone. Thirty-six ASA I or II patients (6-16 yr) were studied. Anaesthesia was induced with thiopentone 5 mg.kg-1. Patients were randomly assigned to receive: (a) atropine 10 micrograms.kg-1 and succinylcholine 1.5 mg.kg-1 (n = 12), (b) atropine 20 micrograms.kg-1 and succinylcholine 1.5 mg.kg-1 (n = 13) or (c) vecuronium 0.1 mg.kg-1 (n = 11) to facilitate tracheal intubation. Heart rate and rhythm were recorded continuously using a computerised analogue interface whereas blood pressure was monitored non-invasively before induction of anaesthesia, immediately before and at one and three minutes after laryngoscopy. No difference was observed between patients who received atropine 10 or 20 micrograms.kg-1 prior to succinylcholine. No episode of sinus bradycardia occurred. Premature atrial contractions were observed in two patients (one succinylcholine/atropine 20 micrograms.kg-1, one vecuronium). Administration of atropine 20 micrograms.kg-1 prior to succinylcholine provides no advantage over atropine 10 micrograms.kg-1 in older children in terms of cardiovascular stability.
在加拿大多伦多病童医院,在婴儿和儿童中,于琥珀酰胆碱给药前给予20微克/千克的阿托品是常见做法。对于年龄较大的儿童(6至16岁),给予此剂量阿托品进行“预防性”用药是否必要尚不清楚。本研究旨在比较给予硫喷妥钠麻醉的大龄儿童10或20微克/千克阿托品后,再给予琥珀酰胆碱或维库溴铵(对照组),其心率、心律和平均动脉压的变化。研究了36例ASA I或II级患者(6至16岁)。用5毫克/千克硫喷妥钠诱导麻醉。患者被随机分配接受:(a) 10微克/千克阿托品和1.5毫克/千克琥珀酰胆碱(n = 12),(b) 20微克/千克阿托品和1.5毫克/千克琥珀酰胆碱(n = 13),或(c) 0.1毫克/千克维库溴铵(n = 11)以利于气管插管。使用计算机模拟界面连续记录心率和心律,而在麻醉诱导前、喉镜检查前以及喉镜检查后1分钟和3分钟无创监测血压。在琥珀酰胆碱给药前接受10或20微克/千克阿托品的患者之间未观察到差异。未发生窦性心动过缓事件。在两名患者中观察到房性早搏(一名琥珀酰胆碱/20微克/千克阿托品,一名维库溴铵)。在大龄儿童中,就心血管稳定性而言,在琥珀酰胆碱给药前给予20微克/千克阿托品并不比给予10微克/千克阿托品更具优势。